Patients with PTEN Hamartoma Tumor Syndrome (PHTS) have high hereditary cancer risks for breast, endometrial, and thyroid cancer.
Patients develop multiple primary cancers, but these risks remain uncertain.
We aimed to provide the second primary cancer risk.
